Send feedback

NEFL p.Arg23Pro

c.68G>C · rs745353207 · VCV1017423

Uncertain significance Multiple submitters
Classification
Uncertain significance
ClinVar
Review
Multiple submitters ★★☆☆
ClinVar · 2 submitters
AlphaMissense
ambiguous
0.5533 · ACMG-weighted
gnomAD v4.1
Rare
very rare (popmax 0.00034%, nfe)
Conditions
1
Charcot-Marie-Tooth disease type 2E

Computational evidence

Protein change
AlphaMissense0.5533ambiguous
SaProtLLR -5.81tolerated
Splicing
SpliceAI—not assessed · no allele here is in the release
Constraint at this position
ConservationphyloP 4GERP 1.9, phastCons 1
Regional constrainto/e 0.93unconstrained · MANE · 3,702 bp · p 0.058 · regional, not allelic
Overall
CADD24.6PHRED · no single calibrated threshold — expert panels disagree

AlphaMissense carries the ACMG weight for missense; SaProt is an independent agreement signal.

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 0.00034% European (non-Finnish) · 4/1,176,030 alleles
Filtering AF 8e-05% ClinGen BA1/BS1 input FAF95, joint · FAF99 5.4e-05%
Overall 0.000312% 5/1,603,916 alleles · very rare exomes 5/1,451,674 · genomes 0/152,242 · joint denominator
Ancestry group Frequency 1 in
Remaining individualsnot grpmax-eligible 0.00161% 62,084
European (non-Finnish)grpmax 0.00034% 294,008

Remaining individuals shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
NEFL
Protein
p.Arg23Pro
Coding
c.68G>C
MANE Select
NM_006158
dbSNP
rs745353207
Type
single nucleotide variant
Location
chr8:24956448 (GRCh38)
Gene constraint
LOEUF 0.986 · pLI <0.01 · ClinGen HI 0/3 (gnomAD)
Structure
AlphaFold pLDDT 73.66
Residue 23
a modified residue (asymmetric dimethylarginine; alternate); a modified residue (omega-n-methylarginine; alternate); the 'head' region
Full NEFL gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Disease context

Charcot-Marie-Tooth disease type 2E — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatments

For Autosomal dominant Charcot-Marie-Tooth disease type 2E (Orphanet):

Inheritance
Autosomal dominant
Onset
Adolescent, Adult, Childhood, Infancy

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/nefl-p-arg23pro (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown